When the checkpoints have gone: insights into Cdc25 functional activation

Seth S Margolis1, Sally Kornbluth

  • 1Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, North Carolina 27710, USA.

Insights

DNA checkpoints prevent mitosis by inhibiting Cdc25 phosphatase. This study reveals 14-3-3 protein removal and involvement of PP1 phosphatase and Cdk2 kinase in Cdc25 activation, offering new insights into checkpoint control.

Area of Science:

  • Cell cycle regulation
  • DNA damage response
  • Mitotic entry control

Background:

  • DNA-responsive checkpoints ensure genomic integrity by halting cell division.
  • These checkpoints prevent premature mitosis (G2/M transition) when DNA is damaged or unreplicated.
  • Cdc25 phosphatase, crucial for activating Cdc2/Cyclin B, is a key target of these checkpoints.

Purpose of the Study:

  • To elucidate the mechanisms by which DNA-responsive checkpoint signaling controls Cdc25 function.
  • To investigate the specific steps involved in Cdc25 activation during mitotic entry.
  • To propose a comprehensive model for Cdc25 activation and its regulation by DNA checkpoints.

Main Methods:

  • Detailed examination of individual steps in Cdc25 activation.
  • Analysis of 14-3-3 protein binding to phosphorylated Cdc25.
  • Investigation of the roles of PP1 phosphatase and Cdk2 kinase in Cdc25 activation.

Main Results:

  • Removal of the regulatory 14-3-3 protein from phosphorylated Cdc25 is an early step in mitotic activation.
  • The phosphatase PP1 and the G1/S kinase Cdk2 are unexpectedly implicated in Cdc25 activation.
  • These findings suggest novel regulatory roles for PP1 and Cdk2 in checkpoint control.

Conclusions:

  • A model for Cdc25 activation is proposed, integrating new findings with existing knowledge.
  • The study identifies novel points of control within DNA-responsive checkpoints governing mitotic entry.
  • Understanding these regulatory loci may reveal new therapeutic targets for cell cycle-related disorders.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...